CAREDX, INC. (CDNA) FY2026 Q2 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2026-04-01 to 2026-06-30

Swipe to see the full flow
CAREDX, INC. cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Calculated remaining financing cash flows are purple; remaining operating and investing bundles are gray. Their underlying inflows and outflows are not separately identified. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income (loss) → Net cash from operating activities: $30,604,000.00Net income (loss) → Operating adjustments reconciliation: $80,032,000.00Accrued compensation → Operating adjustments reconciliation: $17,189,000.00Stock-based compensation → Operating adjustments reconciliation: $10,654,000.00Depreciation and amortization → Operating adjustments reconciliation: $2,811,000.00Inventory → Operating adjustments reconciliation: $2,272,000.00Accounts receivable → Operating adjustments reconciliation: $2,040,000.00Amortization of right-of-use assets → Operating adjustments reconciliation: $1,237,000.00Accounts payable → Operating adjustments reconciliation: $1,197,000.00Accrued and other liabilities → Operating adjustments reconciliation: $846,000.00Amortization of premium and accretion of discount on marketable securities, net → Operating adjustments reconciliation: $502,000.00Other → Operating adjustments reconciliation: $51,000.00Operating adjustments reconciliation → Remaining operating cash flows, net (calculated): $111,932,000.00Operating adjustments reconciliation → Prepaid and other assets: $5,495,000.00Operating adjustments reconciliation → Operating leases liabilities, net: $1,404,000.00Remaining investing cash flows, net (calculated) → investing reconciliation: $282,444,000.00investing reconciliation → Net cash from investing activities: $280,586,000.00investing reconciliation → Additions of property and equipment: $1,858,000.00Net cash used in financing activities → financing reconciliation: $15,498,000.00Proceeds from issuance of common stock under employee stock purchase plan → financing reconciliation: $1,506,000.00Proceeds from exercise of stock options → financing reconciliation: $1,245,000.00financing reconciliation → Repurchase and retirement of common stock: $12,232,000.00financing reconciliation → Taxes paid related to net share settlement of restricted stock units: $6,017,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $78,474,000.00Net cash from operating activities → Cash sources and uses: $30,604,000.00Net cash from investing activities → Cash sources and uses: $280,586,000.00Cash sources and uses → Exchange-rate effect: $9,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $374,157,000.00Cash sources and uses → Net cash used in financing activities: $15,498,000.00Net income (loss): $110,636,000.00Net income (loss)+$110.64 MStock-based compensation: $10,654,000.00Stock-based compensation+$10.65 MDepreciation and amortization: $2,811,000.00Depreciation & amortization+$2.81 MAmortization of right-of-use assets: $1,237,000.00Operating lease amortization+$1.24 MRevaluation of contingent consideration to estimated fair value: $0.00Amortization of premium and accretion of discount on marketable securities, net: $502,000.00Investment discount & premium+$502.00 KOther: $51,000.00Other non-cash items+$51.00 KAccounts receivable: $2,040,000.00Accounts receivable+$2.04 MInventory: $2,272,000.00Inventories+$2.27 MPrepaid and other assets: -$5,495,000.00Prepaid & other current, net−$5.50 MOperating leases liabilities, net: -$1,404,000.00Operating lease liabilities, net−$1.40 MAccounts payable: $1,197,000.00Trade payables+$1.20 MAccrued compensation: $17,189,000.00Accrued salaries & wages+$17.19 MAccrued and other liabilities: $846,000.00Other accrued liabilities+$846.00 KRemaining operating cash flows, net (calculated): -$111,932,000.00Remaining operating (calculated)−$111.93 MNet cash from operating activities: $30,604,000.00Operating cash+$30.60 MOperating adjustments reconciliation: $118,831,000.00Proceeds from issuance of common stock under employee stock purchase plan: $1,506,000.00Stock plan proceeds+$1.51 MTaxes paid related to net share settlement of restricted stock units: -$6,017,000.00Stock-award tax withholding−$6.02 MProceeds from exercise of stock options: $1,245,000.00Stock option exercises+$1.25 MPayment of contingent consideration: $0.00Repurchase and retirement of common stock: -$12,232,000.00Common stock repurchases−$12.23 MNet cash used in financing activities: -$15,498,000.00. Cash required to fund net payments.Financing cash−$15.50 Mfinancing reconciliation: $18,249,000.00Purchases of marketable securities: -$0.00Additions of property and equipment: -$1,858,000.00PP&E purchases−$1.86 MRemaining investing cash flows, net (calculated): $282,444,000.00Remaining investing (calculated)+$282.44 MNet cash from investing activities: $280,586,000.00Investing cash+$280.59 Minvesting reconciliation: $282,444,000.00Cash sources and uses: $389,664,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $78,474,000.00Beginning cash$78.47 MEnding cash: Cash, cash equivalents, and restricted cash: $374,157,000.00Ending cash$374.16 MExchange-rate effect: -$9,000.00FX effect−$9.00 KCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$28.75 MOperating cash − cash spent on PP&ECash flow / Net income0.28×Operating cash flow ÷ net incomeNet cash change+$295.68 MEnding cash − beginning cash
Chart details

CAREDX, INC. cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Mar 31, 2026
78,474,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
30,604,000 US dollars. Net cash provided. The remaining amount is calculated by subtracting the other displayed items from the operating total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Loss on disposal of asset), so Gain on sale of lab products business, Loss on disposal of asset and Deferred revenue cannot be separated for this quarter. It may combine inflows and outflows.
Net income (loss)
110,636,000 US dollars
Stock-based compensation
10,654,000 US dollars
Depreciation and amortization
2,811,000 US dollars
Amortization of right-of-use assets
1,237,000 US dollars
Revaluation of contingent consideration to estimated fair value
0 US dollars
Amortization of premium and accretion of discount on marketable securities, net
502,000 US dollars
Other
51,000 US dollars
Accounts receivable
2,040,000 US dollars
Inventory
2,272,000 US dollars
Prepaid and other assets
negative 5,495,000 US dollars
Operating leases liabilities, net
negative 1,404,000 US dollars
Accounts payable
1,197,000 US dollars
Accrued compensation
17,189,000 US dollars
Accrued and other liabilities
846,000 US dollars
Remaining operating cash flows, net (calculated)
negative 111,932,000 US dollars
Investing activities
280,586,000 US dollars. Net cash provided. The remaining amount is calculated by subtracting the other displayed items from the investing total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Maturities of marketable securities), so Maturities of marketable securities, Sales of marketable securities, Purchase of long term investment and Proceeds from sale of lab products business, net cannot be separated for this quarter. It may combine inflows and outflows.
Purchases of marketable securities
0 US dollars
Additions of property and equipment
negative 1,858,000 US dollars
Remaining investing cash flows, net (calculated)
282,444,000 US dollars
Financing activities
negative 15,498,000 US dollars. Net cash used.
Proceeds from issuance of common stock under employee stock purchase plan
1,506,000 US dollars
Taxes paid related to net share settlement of restricted stock units
negative 6,017,000 US dollars
Proceeds from exercise of stock options
1,245,000 US dollars
Payment of contingent consideration
0 US dollars
Repurchase and retirement of common stock
negative 12,232,000 US dollars
Operating adjustment reconciliation
118,831,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
financing gross reconciliation
18,249,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing displayed reconciliation
282,444,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
Exchange-rate effect
negative 9,000 US dollars
Ending cash on Jun 30, 2026
374,157,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
389,664,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
295,683,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
0.28×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
30,604,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
1,858,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
28,746,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income exceeds operating cash. The diagram allocates $30.60M of net income directly to operating cash and $80.03M to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 30,604,000 US dollars minus 1,858,000 US dollars equals 28,746,000 US dollars.
CAREDX, INC. (CDNA) FY2026 Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!